We have previously established that rapamycin (a selective mTOR inhibitor), and metformin (an indirect inhibitor of mTOR signaling through its effects on gluconeogenesis and associated activation of AMPK-regulated signals), partially mimic the tumor inhibitory effects of CR on transplanted pancreatic tumor growth [13]. The gene discussed is MTOR; the disease is neoplasm.